98%
921
2 minutes
20
Murine laser-induced laser choroidal neovascularization is a widely used and robust model of wet (exudative) age-related macular degeneration (wAMD). wAMD is one of the leading causes of blindness in the Western world. In brief, a focused laser beam is used to penetrate Bruch's membrane, which separates the choriocapillaris (well-vascularized choroid layer) from the pigmented layers of the retina. Damage to the integrity of this membrane during diabetes leads to fluid accumulation and vascular invasion into the subretinal layers resulting in a progressive worsening of vision. Here we describe a 14-day model using untreated C57/Bl6 mice, but it is equally applicable to incorporation into transgenic studies and therapeutic agent development (such as eye drops), injection of therapeutic agents (including antibodies), and for longer time course studies. In vivo functional analysis or lesioned choroids can be studied with further immunohistochemical staining for further analyses.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-2059-5_17 | DOI Listing |
FASEB J
September 2025
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Proliferative diabetic retinopathy (PDR) is a complication of diabetic microangiopathy that can cause severe visual impairment. Due to retinal neovascularization and fibrovascular membrane (FVM) formation, inhibition of vascularization and fibrosis plays a key role in PDR. In our study, single-cell sequencing of FVMs from PDR patients identified a MARCO microglial subpopulation exhibiting both pro-angiogenic and pro-fibrotic effects.
View Article and Find Full Text PDFInt J Ophthalmol
September 2025
School of Clinical Medicine, Medical College of Soochow University, Suzhou 215006, Jiangsu Province, China.
Aim: To investigate cuproptosis-related molecular and immune infiltration in age-related macular degeneration (AMD) development and establish a predictive model.
Methods: The expression profiles of cuproptosis-related genes and immune signature in AMD based on the microarray dataset GSE29801 were analyzed. A total of 142 AMD samples were used to identify the cuproptosis-related differentially expressed genes (Cu-DEGs), together with the immune cell infiltration.
Sci Rep
August 2025
Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Ocular Inflammation Group, Barcelona, Spain.
Choroidal neovascularization (CNV) and inflammation play an important role in retinal disease development and the acute phase reactant C-reactive protein (CRP) has been shown to contribute to Age-related macular degeneration (AMD) in vitro. Our aim was to evaluate whether monomeric and pentameric CRP (pCRP, mCRP) isoforms contribute to CNV in vivo and to characterize the mechanism of CRP dissociation in-vivo and in vitro. Both CRP isoforms were intravitreally (IVT) or intravenously (IV) injected in mice, CNV was laser-induced, retinography and fluorescein angiography were performed to evaluate edema.
View Article and Find Full Text PDFDiagnostics (Basel)
August 2025
Department of Ophthalmology, Toho University Graduate School of Medicine, Tokyo 143-8541, Japan.
This study aims to investigate ocular blood flow in male subjects with metabolic syndrome (MetS) using laser speckle flowgraphy (LSFG). Subjects who underwent LSFG ocular blood flow testing during physical examinations were separated into a MetS group and a control group. The groups were propensity score-matched by age, with 138 male subjects compared in each group.
View Article and Find Full Text PDFInt J Mol Sci
August 2025
Department of Biochemistry, Molecular Biology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness worldwide, primarily due to pathological choroidal neovascularization (CNV). Our study investigates a chemically modified heparin derivative as a novel strategy to selectively modulate angiogenic signaling, offering a reduced anticoagulant risk and preclinical support for AMD treatment. We explored the therapeutic potential of 6-O-desulfated heparin (Hep-6Od) as an antiangiogenic agent with diminished anticoagulant activity.
View Article and Find Full Text PDF